Literature DB >> 10064249

Cryptococcosis in children with AIDS.

J Abadi1, S Nachman, A B Kressel, L Pirofski.   

Abstract

We compiled the clinical and immunologic features of Cryptococcus neoformans infections in human immunodeficiency virus (HIV)-infected children from 1985 to 1996 in a retrospective case series. Thirty cases of cryptococcosis were identified. These children had a median age of 9.8 years, a median CD4+ cell count of 54/microL at the time of diagnosis, and either a culture positive for C. neoformans or cryptococcal antigen in serum or cerebrospinal fluid. Sixty-three percent of the cases occurred in children vertically infected with HIV and in children between 6 and 12 years of age. The clinical and laboratory characteristics of this pediatric cohort were similar to those of adults with AIDS and cryptococcosis. On the basis of a subset of the cases, a 10-year point prevalence of cryptococcosis among children with AIDS of approximately 1% was estimated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064249     DOI: 10.1086/515130

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Clinical characteristics and prognosis of pediatric cryptococcosis in Beijing Children's Hospital, 2002-2014.

Authors:  Linlin Liu; Lingyun Guo; Yue Liu; Tianming Chen; Shaoying Li; Yonghong Yang; Gang Liu
Journal:  Eur J Pediatr       Date:  2017-08-03       Impact factor: 3.183

2.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

3.  ISOLATION OF Cryptococcus neoformans FROM ENVIRONMENTAL SAMPLES COLLECTED IN SOUTHEASTERN NIGERIA.

Authors:  Emeka I Nweze; Fred A Kechia; Uju E Dibua; Charles Eze; Uwakwe S Onoja
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jul-Aug       Impact factor: 1.846

4.  STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Mathias Mueller; Floyd L Wormley
Journal:  Infect Immun       Date:  2015-09-08       Impact factor: 3.441

Review 5.  Paradoxical roles of alveolar macrophages in the host response to Cryptococcus neoformans.

Authors:  Travis J McQuiston; Peter R Williamson
Journal:  J Infect Chemother       Date:  2011-11-02       Impact factor: 2.211

6.  Analyses of pediatric isolates of Cryptococcus neoformans from South Africa.

Authors:  Kathleen J Miglia; Nelesh P Govender; Jenny Rossouw; Susan Meiring; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

Review 7.  Cryptococcal Disease in HIV-Infected Children.

Authors:  Carol Kao; David L Goldman
Journal:  Curr Infect Dis Rep       Date:  2016-09       Impact factor: 3.725

8.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

9.  STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.

Authors:  Chrissy M Leopold Wager; Camaron R Hole; Karen L Wozniak; Michal A Olszewski; Floyd L Wormley
Journal:  J Immunol       Date:  2014-09-08       Impact factor: 5.422

10.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.